Stocks TelegraphStocks Telegraph
Stock Ideas

ST Premium

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!

HRTX Financial Statements and Analysis

NASDAQ : HRTX

Heron Therapeutics, Inc.

$2.24
-0.23-9.31%
At Close 4:00 PM
$2.40
0.15+6.70%
After-Market 07:15 PM
67.01
B-ESG ScoreESG Rating

HRTX FINANCIAL STATEMENTS

An instrumental part of fundamental analysis is measuring key indicators of an asset, which are the factors that can influence its value and price. However, sometimes investors show more interest in financial statements with other factors to determine whether investing in that company is the right decision. Financial statements of a company include:

  • Balance Sheet
  • Income Statement
  • Cash Flow Statement

HRTX Income Statement

A company's income statement helps investors and business owners determine whether the company is profitable or losing money. Profitability is a key factor investors consider before investing in a stock. Income statements provide them with information about a company's profitability over time. The statement also enables them to observe trends in company spending and earnings since it breaks down individual costs and revenues. Income statements also provide details on where a company's money is going when it isn't profitable or its profits fluctuate.

Date2024-09-302024-06-302024-03-312023-12-312023-09-30
reported currencyUSDUSDUSDUSDUSD
calendar year20242024202420232023
periodQ3Q2Q1Q4Q3
revenue42.268M36.024M34.67M34.233M31.434M
cost of revenue18.916M10.518M8.444M9.885M18.208M
gross profit23.352M25.506M26.226M24.348M13.226M
gross profit ratio0.5520.7080.7560.7110.421
research and development expenses4.465M4.432M4.608M10.95M13.558M
general and administrative expenses12.373M13.905M14.974M11.29M11.641M
selling and marketing expenses10.972M13.614M11.442M12.328M12.956M
selling general and administrative expenses23.345M27.519M26.416M23.618M24.597M
other expenses001.638M0-79.00K
operating expenses27.81M31.951M31.024M34.568M38.155M
cost and expenses46.726M42.469M39.468M44.453M56.363M
interest income00000
interest expense0002.168M563.00K
depreciation and amortization0641.00K689.00K715.00K727.00K
ebitda-4.458M-5.804M-4.109M-9.505M-24.202M
ebitda ratio-0.105-0.161-0.119-0.278-0.77
operating income-4.458M-6.445M-4.798M-10.22M-24.929M
operating income ratio-0.105-0.179-0.138-0.299-0.793
total other income expenses net-390.00K-2.79M1.638M-504.00K-79.00K
income before tax-4.848M-9.235M-3.16M-10.724M-25.008M
income before tax ratio-0.115-0.256-0.091-0.313-0.796
income tax expense00645.724K00
net income-4.848M-9.235M-3.16M-10.724M-25.008M
net income ratio-0.115-0.256-0.091-0.313-0.796
eps-0.032-0.061-0.021-0.071-0.17
eps diluted-0.032-0.061-0.021-0.071-0.17
weighted average shs out152.83M152.305M151.199M150.285M144.99M
weighted average shs out dil152.83M152.305M151.199M150.285M144.99M
Graph

HRTX Balance Sheet

Balance sheet summarizes a company's financials and can be used as a basis by investors to determine the value of a company. It shows the value of the stock, as well as the assets and liabilities of the company. A company's balance sheet displays how its assets are put to use and how those assets are financed, based on the liabilities section. Both investors and analysts analyze a company's balance sheet to determine how it allocates its resources.

Date2024-09-302024-06-302024-03-312023-12-312023-09-30
reported currencyUSDUSDUSDUSDUSD
calendar year20242024202420232023
periodQ3Q2Q1Q4Q3
cash and cash equivalents25.741M18.386M20.45M28.677M34.859M
short term investments45.149M48.961M51.074M51.732M42.553M
cash and short term investments70.89M67.347M71.524M80.409M77.412M
net receivables67.039M73.708M65.322M60.137M63.795M
inventory45.95M42.864M42.473M42.11M42.007M
other current assets11.308M7.249M6.584M6.118M10.765M
total current assets195.187M191.168M185.903M188.774M193.979M
property plant equipment net18.883M20.038M24.10M25.604M26.854M
goodwill00000
intangible assets00000
goodwill and intangible assets00000
long term investments00000
tax assets00000
other non current assets6.707M6.93M7.884M8.128M8.366M
total non current assets25.59M26.968M31.984M33.732M35.22M
other assets00000
total assets220.777M218.136M217.887M222.506M229.199M
account payables10.188M10.226M837.00K3.24M1.86M
short term debt3.249M6.388M3.137M3.075M2.999M
tax payables00000
deferred revenue00000
other current liabilities72.107M63.703M71.404M73.37M74.886M
total current liabilities85.544M80.317M75.378M79.685M79.745M
long term debt174.997M175.518M176.034M173.753M176.999M
deferred revenue non current00000
deferred tax liabilities non current00000
other non current liabilities241.00K241.00K240.999K3.041M241.00K
total non current liabilities175.238M175.759M176.275M176.794M177.24M
other liabilities001.0000
capital lease obligations3.771M4.483M2.045M2.80M6.536M
total liabilities260.782M256.076M251.653M256.479M256.985M
preferred stock00000
common stock1.517M1.516M1.504M1.503M1.411M
retained earnings-1.923B-1.918B-1.909B-1.906B-1.895B
accumulated other comprehensive income loss40.00K-8.00K-6.00K13.00K-1.00K
other total stockholders equity1.882B1.879B1.874B1.871B1.866B
total stockholders equity-40.005M-37.94M-33.766M-33.973M-27.786M
total equity-40.005M-37.94M-33.766M-33.973M-27.786M
total liabilities and stockholders equity220.777M218.136M217.887M222.506M229.199M
minority interest00000
total investments45.149M48.961M51.074M51.732M42.553M
total debt178.246M178.712M179.171M179.628M179.998M
net debt152.505M160.326M158.721M150.951M145.139M
Graph

HRTX Cash Flow

A cash flow statement is regarded as a valuable indicator of profitability and the long-term outlook for a company. It assists the company in evaluating whether it has sufficient funds to cover its expenses. Essentially, a cash flow statement represents an organization's financial health. The cash flow statement, which measures the business's ability to operate in the short as well as long term, is broken down into operating, investing, and financing activities.

Date2024-06-302024-03-312023-12-312023-09-302023-06-30
reported currencyUSDUSDUSDUSDUSD
calendar year20242024202320232023
periodQ2Q1Q4Q3Q2
deferred income tax00-819.00K-184.00K-183.00K
stock based compensation4.57M3.375M4.324M6.683M13.90M
change in working capital-3.422M-10.092M8.402M8.53M386.00K
accounts receivables-8.386M-5.185M3.658M12.898M-25.245M
inventory-391.00K-363.00K-103.00K2.616M7.436M
accounts payables9.389M-2.403M1.38M-97.00K-2.108M
other working capital-4.034M-2.141M3.467M-6.887M20.303M
other non cash items8.082M12.376M557.00K73.00K52.00K
net cash provided by operating activities-4.604M-9.516M2.455M-9.179M-27.165M
investments in property plant and equipment-637.00K0-250.00K-793.00K-278.00K
acquisitions net0013.00K0-13.496M
purchases of investments-27.208M-37.892M-23.349M-35.928M-14.439M
sales maturities of investments29.893M39.17M14.75M13.50M27.935M
other investing activites2.685M1.278M0013.496M
net cash used for investing activites2.048M1.278M-8.836M-23.221M13.218M
debt repayment00-29.755M-54.105M0
common stock issued492.00K11.00K29.954M-308.00K319.00K
common stock repurchased00000
dividends paid00000
other financing activites492.00K11.00K0108.21M319.00K
net cash used provided by financing activities492.00K11.00K199.00K53.797M319.00K
effect of forex changes on cash00000
net change in cash-2.064M-8.227M-6.182M21.397M-13.628M
cash at end of period18.386M20.45M28.677M34.859M13.462M
cash at beginning of period20.45M28.677M34.859M13.462M27.09M
operating cashflow-4.604M-9.516M2.455M-9.179M-27.165M
capital expenditure-637.00K0-250.00K-793.00K-278.00K
free cash flow-5.241M-9.516M2.205M-9.972M-27.443M
Graph

Frequently Asked Questions

How did Heron Therapeutics, Inc. do last quarter? What was its Total Revenue and Cost of Revenue?

A company's Total Revenue reveals how much money it generates before any expenses or deductions are made. As a result, this metric informs investors/stakeholders how much money the business makes. Tracking and understanding it is essential for evaluating a company's growth. As opposed to revenue, Cost of Revenue is any expenses a business incur to generate revenue. There can be high revenue in a business, but if the costs are high, it won't make a profit and will go out of business when money runs out. Therefore, HRTX generated $42.27M in revenue last quarter, while its costs came in at $18.92M.

Last quarter, how much Gross Profit did Heron Therapeutics, Inc. report?

A business's Gross Profit is a key indicator of its profitability and financial performance. In other words, it reflects how efficiently a business uses labor, raw materials, and other resources. Heron Therapeutics, Inc. reported a $23.35M Gross Profit for the quarter ended Jun 30, 2024.

Have HRTX's Total Operating Expenses and Operating Income been favorable recently?

Operational Expenses represent the costs a company must incur to generate revenue, which is the ultimate goal of a business, whereas Operating Income shows the revenue left after operational direct and indirect costs have been deducted. HRTX incurred $27.81M worth of Operating Expenses, while it generated -$4.46M worth of Operating Income.

How much Net Income has HRTX posted recently?

The Net Income of a company is one of the factors investors consider when investing in the company. According to recent earnings report from Heron Therapeutics, Inc., the company generated -$4.85M in Net Income. When a company has a history of consistent net income, investors are more likely to invest in it since they know they will get a return.

At the end of the last quarter, how much Cash and Equivalents did Heron Therapeutics, Inc. have?

The amount of Cash and Cash Equivalents is an effective indicator of the financial strength and well-being of a company. An excess cash situation occurs when a company has more cash and cash equivalents than it needs for operating activities. The amount of Cash and Cash Equivalents available to Heron Therapeutics, Inc. as of the end of the last quarter was $25.74M.

What are HRTX's Total Net Receivables for the last quarter?

Total Net Receivables are a company's outstanding debts to its customers. Therefore, it refers to the amount that a company expects to collect from its customers. The higher a company's net receivables are, the more confident it is that it can collect money from its debtors. As of the end of the last quarter, HRTX had Total Net Receivables of $67.04M.

In terms of Total Assets and Current Assets, where did Heron Therapeutics, Inc. stand at?

An asset with an economic value within a year is considered a current asset. Total assets, however, also include long-term fixed assets, intangible assets, and other non-current assets. The current Assets of HRTX were $195.19M, while the Total Assets stand at $220.78M.

As of the last quarter, how much Total Debt did Heron Therapeutics, Inc. have?

The total debt of a business refers to how much it borrows. A company's current and long-term liabilities are added together to calculate its Total Debt. A debt ratio may be taken into account on a balance sheet by financial lenders, investors, and business leaders when making informed decisions about future loans or investments. The total amount of HRTX's debt was $178.25M at the end of the last quarter.

What were HRTX's Total Liabilities during the last reported quarter?

A company's total liabilities are the sum of all debts it is liable for, including any off-balance shee liabilities it may incur. This can be calculated by adding up all short-term and long-term liabilities. In its last quarter, HRTX reported total liabilities of $260.78M.

How much did HRTX's Working Capital change over the last quarter?

Working Capital Change for HRTX was -$3.42M over the last quarter. Working Capital Change refers to the difference between net working capital amounts at the end of one accounting period and the end of another. It tells investors/stakeholders how much the company's cash flow will differ from its Net Income (i.e., after-tax profits). More powerful companies often have positive Change in Working Capital numbers as they have increased control over collecting cash from customers and delaying payments to suppliers.

HRTX generated how much cash from operating activities?

An operating cash flow statement usually contains cash from operating activities in the first section. An organization's cash from operating activities refers to the money it takes in and takes out as a result of its regular business operations. HRTX generated -$4.60M of Cash from Operating Activities during its recently reported quarter.

What was HRTX's latest reported Net Change in Cash?

An increase or decrease in cash and cash equivalent balances within a specified period is considered the net change in cash in a cash flow statement. Furthermore, it takes into account cash changes as a result of investments, financing, and operating activities. HRTX reported a -$2.06M Net Change in Cash in the most recent quarter.

logo

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com

stockstelegraph

Don't have an account?

stockstelegraph

Don't have an account?

stockstelegraph

Already have an account?

stockstelegraph
Smart Screening Tools for Exceptional Returns
stockstelegraph

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!
stockstelegraph